NDC Code(s) : 68462-225-17, 68462-225-55
Packager : Glenmark Pharmaceuticals Inc., USA
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
| Mometasone FuroateMometasone furoate OINTMENT | ||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
| LABELER - Glenmark Pharmaceuticals Inc., USA(130597813) |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
| Glenmark Pharmaceuticals Limited | 676115028 | ANALYSIS(68462-225), MANUFACTURE(68462-225) | |
PRINCIPAL DISPLAY PANEL
NDC 68462-225-55
Mometasone Furoate Ointment USP, 0.1%
For topical use only. Not for opthalmic use.

PRINCIPAL DISPLAY PANEL
NDC 68462-225-55
Mometasone Furoate Ointment USP, 0.1%
For topical use only. Not for opthalmic use.








